http://orcid.org/0000-0003-1519-7419
References
- Chun LJ, Tong MJ, Busuttil RW. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43:342–349.
- Craig DG, Bates CM, Davidson JS, et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 2012;73:285–294.
- Reuben A, Tillman H, Fontana RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016;164:724–732.
- Gow PJ, Jones RM, Dobson JL, et al. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol. 2004;19:154–159.
- Dalhoff K, Andersen J, Clemmensen O, et al. Behandling af Paracetamolforgiftning-en ny Guideline. 2013. Accessed: 2018 Sept. Available from: https://www.sst.dk/da/rationel-farmakoterapi/maanedsbladet/2013/rationel-farmakoterapi-2,-2013/behandling_af_paracetamolforgiftning__en_ny_guideline
- Heard K, Newton A. Paracetamol overdose: BMJ best practice. Updated April 2018 (Accessed: 2018 Sept). Available from: https://bestpractice.bmj.com/topics/en-gb/337
- Farrell S, Defendi G. Acetaminophen toxicity: Medscape; 2016. (Accessed: 2018 Sept). Available from: http://emedicine.medscape.com/article/820200-overview
- Chiew AL, Fountain JS, Graudins A, et al. Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2015;203:215–218.
- Daly FF, O’Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med. 2004;44:393–398.
- Wong A, Sivilotti MLA, Graudins A, et al. Analysis of an 8-hour acetylcysteine infusion protocol for repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol. 2017;55:346–351.
- Alhelail MA, Hoppe JA, Rhyee SH, et al. Clinical course of repeated supratherapeutic ingestion of acetaminophen. Clin Toxicol. 2011;49:108–112.
- Sivilotti ML, Green TJ, Langmann C, et al. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol. 2010;48:793–799.
- Ryan NM, Isbister GK. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol. 2015;53:545–550.
- Wong A, Sivilotti ML, Dargan PI, et al. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol. 2015;53:807–814.
- Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–1100.
- Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006;296:87–93.
- Heard KJ, Green JL, Dart RC. Serum alanine aminotransferase elevation during 10 days of acetaminophen use in nondrinkers. Pharmacotherapy. 2010;30:818–822.
- Daly FF, Fountain JS, Murray L, et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand–explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008;188:296–301.